Artivion | CRY - 资产



金融业
股票价格
USD
资产
USD 1.07B
现金及等价物
USD 77.32M
销售成本
USD 42.85M
流动资产
USD 371.38M
流动负债
USD 106.93M
债务
USD 317.78M
EBIT
USD 4.79M
EBITDA
USD 22.72M
员工
1.5K
EPS每股收益
USD -0.02
股本和储备
USD 445.59M
销售毛利
USD 73.14M
债务利息支出
USD 5.53M
利息收入
USD -0.05
贷款资金
USD 363.42M
市值
USD 878.1M
净收入
USD 2.42M
营业费用
USD 111.2M
营业利润
USD 4.79M
普通股股本
USD 47.84M
PE价格收益
212.38
税前利润
USD 11.4M
销售收入
USD 115.99M
销售和管理费用
USD 55.75M
股票
USD 103.36M
贸易债权人
USD 20.87M
应收帐款人
USD 103.68M


资产 更改 日
Abbott USD 110.43B 23.72B 2026-03
Accuray USD 448.01M 8.81M 2025-12
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 1.07B 188.78M 2026-06
AtriCure USD 676.64M 32.66M 2026-06
Baxter International USD 19.79B 55M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Inogen USD 307.01M 5.03M 2025-09
Integra LifeSciences USD 3.56B 14.24M 2026-06
J&J USD 201.06B 167M 2026-06
Mesa Laboratories USD 434.85M 4.5M 2025-12
Orthofix International USD 873.02M 13.58M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
ResMed USD 8.97B 181.66M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Terumo JPY 2.37T 61.86B 2026-06
Trinity Biotech USD 105.16M 1.45M 2025-12